In a new policy article, authors from the International Agency for Research on Cancer (IARC) and a large number of partner European cancer organizations provide a detailed view of the infrastructures required to promote excellence in cancer research. They also emphasize consensus priority areas to realize the objectives of the Cancer Mission, and outline recommendations for engaging professionals and institutions throughout the European Union (EU). The article was published today in the journal Molecular Oncology.
IARC, through its strong capabilities in epidemiology, biostatistics, data acquisition capacity, and advanced computational proficiency, will inform initiatives in primary and secondary prevention of cancer and will aid in assessing progress made towards achieving the Cancer Mission objectives. This will lead to successfully achieving the objectives.
The objectives of the Cancer Mission are to unite countries to substantially reduce the cancer burden in the EU, to improve the quality of life of patients with cancer, and to achieve a 10-year cancer-specific survival for 75% of the adult patients diagnosed in 2030 in EU Member States with a well-developed health-care system. Achieving these objectives will require EU-wide harmonization of priorities and policies, improved research coordination, and increasingly efficient and flexible funding mechanisms.
Berns A, Ringborg U, Celis JE, Heitor M, Aaronson NK, Abou Zeid N, et al.
Towards a cancer mission in Horizon Europe: recommendations
Mol Oncol, Published online 4 August 2020;